An article in the January issue of Therapeutic Innovation and Regulatory Science (formerly the Drug Information Journal) offers continuing insights into how the pharmaceutical and biotechnology industries and their regulators need to be thinking about drug development for the future … and these insights are particularly appropriate when it comes to the rare disease space. read more >
RareDisease Dialog is the official blog for the National Organization for Rare Disorders (NORD). NORD’s staff and friends will share information of interest to the entire rare disease community.
Featured Partnerships |
Translate This page: |
|
SUBSCRIBE TO OUR E-NEWS |


